Stanislav Drápela

626 total citations
19 papers, 385 citations indexed

About

Stanislav Drápela is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Stanislav Drápela has authored 19 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Stanislav Drápela's work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related Molecular Pathways (4 papers). Stanislav Drápela is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related Molecular Pathways (4 papers). Stanislav Drápela collaborates with scholars based in Czechia, United States and Germany. Stanislav Drápela's co-authors include Karel Souček, Jan Bouchal, Zoran Čulig, Mohit Kumar Jolly, Ana P. Gomes, Didem Ilter, Kamil Paruch, Lukáš Maier, Benedict‐Tilman Berger and Stefan Knapp and has published in prestigious journals such as Angewandte Chemie International Edition, Cancer Research and Oncogene.

In The Last Decade

Stanislav Drápela

18 papers receiving 381 citations

Peers

Stanislav Drápela

MB

CR

ONCOL

PRM

OC

Yu Hyun Jeon South Korea

Carolina Hassibe Thomé Brazil

Mariya Ilcheva United States

Etna Abad Spain

Asieh Emami Nejad Iran

Najah Albadari United States

Simin Najafgholian Iran

Yanbo Zheng China

Derek P. Logsdon United States

Luca Pompili Italy

Yu Hyun Jeon South Korea

Stanislav Drápela

389 ×1.7

MB

104 ×0.9

CR

117 ×1.0

ONCOL

37 ×0.9

PRM

32 ×1.0

OC

Citations per year, relative to Stanislav Drápela Stanislav Drápela (= 1×) peers Yu Hyun Jeon

Countries citing papers authored by Stanislav Drápela

Since Specialization

Citations

This map shows the geographic impact of Stanislav Drápela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislav Drápela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislav Drápela more than expected).

Fields of papers citing papers by Stanislav Drápela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanislav Drápela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislav Drápela. The network helps show where Stanislav Drápela may publish in the future.

Co-authorship network of co-authors of Stanislav Drápela

This figure shows the co-authorship network connecting the top 25 collaborators of Stanislav Drápela. A scholar is included among the top collaborators of Stanislav Drápela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanislav Drápela. Stanislav Drápela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Elkholi, Islam E., Amélie Robert, Jia Wu, et al.. (2025). Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation. Cancer Research. 85(12). 2179–2198. 1 indexed citations

2.

Drápela, Stanislav, Didem Ilter, Dorina Avram, et al.. (2024). Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8+ T cells to suppress anti-tumor immunity. Oncogene. 44(2). 105–114. 4 indexed citations

3.

Drápela, Stanislav, et al.. (2024). Metabolic landscape of disseminated cancer dormancy. Trends in cancer. 11(4). 321–333. 6 indexed citations

4.

Drápela, Stanislav, Roland Rad, Didem Ilter, et al.. (2024). Abstract A013: Microenvironment driven dynamic deposition of histone H3.3 controls entry and exit from dormancy in disseminated cancer cells. Cancer Research. 84(22_Supplement). A013–A013. 1 indexed citations

5.

Drápela, Stanislav, et al.. (2023). Circulating tumor cell-derived preclinical models: current status and future perspectives. Cell Death and Disease. 14(8). 530–530. 19 indexed citations

6.

Ilter, Didem, Stanislav Drápela, Tanya Schild, et al.. (2023). NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis. Redox Biology. 61. 102627–102627. 21 indexed citations

7.

Gomes, Ana P., Didem Ilter, Vivien Low, et al.. (2022). Altered propionate metabolism contributes to tumour progression and aggressiveness. Nature Metabolism. 4(4). 435–443. 54 indexed citations

8.

Drápela, Stanislav, Didem Ilter, & Ana P. Gomes. (2022). Metabolic reprogramming: a bridge between aging and tumorigenesis. Molecular Oncology. 16(18). 3295–3318. 21 indexed citations

9.

Drápela, Stanislav, et al.. (2022). High-Throughput, Parallel Flow Cytometry Screening of Hundreds of Cell Surface Antigens Using Fluorescent Barcoding. Methods in molecular biology. 2543. 99–111.

10.

Kharaishvili, Gvantsa, et al.. (2022). Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer. Klinicka onkologie. 35(6). 473–481. 3 indexed citations

11.

Němec, Václav, Lukáš Maier, Benedict‐Tilman Berger, et al.. (2021). Highly selective inhibitors of protein kinases CLK and HIPK with the furo[3,2-b]pyridine core. European Journal of Medicinal Chemistry. 215. 113299–113299. 18 indexed citations

12.

Drápela, Stanislav & Ana P. Gomes. (2021). Metabolic requirements of the metastatic cascade. Current Opinion in Systems Biology. 28. 100381–100381. 6 indexed citations

13.

Drápela, Stanislav, Jan Bouchal, Mohit Kumar Jolly, Zoran Čulig, & Karel Souček. (2020). ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance. Frontiers in Molecular Biosciences. 7. 36–36. 117 indexed citations

14.

Drápela, Stanislav, Prashant Khirsariya, Wytske M. van Weerden, et al.. (2020). The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe. Molecular Oncology. 14(10). 2487–2503. 19 indexed citations

15.

Khirsariya, Prashant, Marek Borský, Jan Verner, et al.. (2019). Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells. Haematologica. 104(12). 2443–2455. 22 indexed citations

16.

Drápela, Stanislav, et al.. (2019). Flow Cytometric Analysis of Nucleoside Transporters Activity in Chemoresistant Prostate Cancer Model.. PubMed. 31(Supplementum1). 140–144. 1 indexed citations

17.

Němec, Václav, Lukáš Maier, Jana Flegel, et al.. (2018). Furo[3,2‐b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway. Angewandte Chemie International Edition. 58(4). 1062–1066. 45 indexed citations

18.

Němec, Václav, Lukáš Maier, Jana Flegel, et al.. (2018). Furo[3,2‐b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway. Angewandte Chemie. 131(4). 1074–1078. 17 indexed citations

19.

Maier, Lukáš, et al.. (2017). Diastereoselective Flexible Synthesis of Carbocyclic C-Nucleosides. The Journal of Organic Chemistry. 82(7). 3382–3402. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact